TACEEDO RTU 120 MG Injection

Name: TACEEDO RTU 120 MG Injection
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

TACEEDO RTU 120 MG Injection Specification

Indication
Breast Cancer

Dosage Form
Injection

Salt Composition
Docetaxel

Feature
Ready-to-use solution, cytotoxic

Ingredients
Docetaxel concentrate for solution for infusion

Application
For I.V. infusion

Physical Color/Texture
Clear liquid, colorless or pale yellow

Storage Instructions
Store below 25C, protect from light

Shelf Life
As per packaging/label

Solution Type
Concentrate

Pack Type
Vial

Form of Medicine
Liquid

Strength
120 mg/6ml

Packaging Size
6 ml

Pharmacopoeial Standard
IP

Prescription
Rx only

Administration Route
Intravenous

Vial Cap Color
Blue

Box Color
White & Blue

Ready To Use
Yes

Therapeutic Class
Antineoplastic

TACEEDO RTU 120 MG Injection Trade Information

Minimum Order Quantity
5 Vials

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About TACEEDO RTU 120 MG Injection

Unlock the benefits of TACEEDO RTU 120 MG Injection-a superlative, ready-to-use treatment designed for intravenous administration in the fight against breast cancer. This sterling solution features competitive pricing, making high-quality Docetaxel therapy accessible for all healthcare providers. Provided in a 6 ml vial with white & blue packaging and a blue cap, this concentrate complies with IP standards. As a paragon of reliability among antineoplastic therapies, TACEEDO RTU is the last chance solution for patients needing fast, effective cancer intervention. Exclusively Rx, cytotoxic, and manufacturer-direct from India.

Commercial Applications and Usage Areas

TACEEDO RTU 120 MG Injection is widely utilized in oncology clinics and hospitals for breast cancer treatment. Its ready-to-use format ensures convenience for healthcare professionals involved in intravenous chemotherapy. With precise composition and high therapeutic efficacy, it fits seamlessly into modern antineoplastic protocols. The medicine is suitable for commercial use by exporters, suppliers, and institutions requiring a sterile, concentrated Docetaxel infusion, offering a reliable solution for those focused on competitive oncology care.

Domestic Market, Payment, and Sample Policy Details

TACEEDO RTU 120 MG Injection serves a broad domestic market across India with easy payment options to streamline the purchasing process. The product is dispatched with secure shipping and protective packaging, maintaining integrity during transportation. We uphold a sample policy tailored for hospitals and procurement agents, ensuring they can verify product quality before making procurement decisions. Efficient logistics and attentive customer support further guarantee swift, safe delivery to end-users nationwide.

FAQ's of TACEEDO RTU 120 MG Injection:

Q: How is TACEEDO RTU 120 MG Injection administered?

A: TACEEDO RTU 120 MG Injection is administered via intravenous infusion under the supervision of qualified healthcare professionals. It comes as a ready-to-use concentrate, streamlining preparation and dosing for clinical staff.

Q: What benefits does the ready-to-use formulation offer?

A: The ready-to-use (RTU) formulation saves preparation time, reduces handling errors, and minimizes exposure to cytotoxic drugs, increasing safety and efficiency for medical staff and patients alike.

Q: Where can TACEEDO RTU 120 MG Injection be purchased?

A: TACEEDO RTU can be obtained through certified exporters, manufacturers, and suppliers in India, generally requiring a valid prescription for procurement in medical institutions or pharmacies.

Q: What is the storage guideline for TACEEDO RTU 120 MG Injection?

A: Store the injection below 25C and protect it from light. Always refer to the specific packaging or label for detailed storage instructions and adhere to best practices for cytotoxic medicines.

Q: Who can use TACEEDO RTU 120 MG Injection?

A: This injection is indicated for patients with breast cancer, prescribed by oncologists, and intended for use in controlled clinical settings where intravenous chemotherapy is administered.

Q: When can a healthcare provider request a sample of this medicine?

A: Hospitals and procurement agents may request a sample as per the supplier's sample policy, often after initial inquiry or as part of a bulk purchasing process to ensure it meets institutional standards.